| Literature DB >> 35004606 |
Yuqin Yang1, Feifei Li1, Mengmeng Yan1, Shan Chen1, Desheng Cai1, Xiaojing Liu1, Nana Han1, Zhihua Yuan1, Jihui Lu1, Yaozhi Zhang1, Qiang Ma2, Penglong Wang1, Haimin Lei1.
Abstract
Researchers often focus on the mechanisms of synergistic agents, a few explore drug combinations that enhance toxicity, while few have studied the internal mechanism of compatibility enhancement in chemical level. Herein, we present a comprehensive analysis based on ultra-high-performance liquid chromatography coupled with quadrupole-Orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) and a self-assembled supramolecular strategy, which reveals the toxicity-enhancing essence of glycyrrhizic acid originated in licorice when combined with Genkwa Flos. Through this method, we discovered the toxicity was enhanced through the formation of a supramolecular complex from Genkwa Flos/glycyrrhizic acid. The morphology and size distribution of the self-assembled nanoparticles were characterized by scanning electron microscopy and dynamic light scattering Furthermore, a total of 58 constituents (eight diterpenoids, 35 flavonoids, five phenylpropanoids, four nucleosides, two amino acids, and four other compounds) consisted from the supramolecular complex were identified through accurate-mass measurements in full-scan MS/data-dependent MS/MS mode. Based on the hydrophobic interaction of glycyrrhizic acid with yuanhuacine (one of main ingredients from Genkwa Flos), the supramolecular self-assembly mechanism was revealed with proton nuclear magnetic resonance (1H-NMR) and NOESY 2D NMR. The toxicity of Genkwa Flos and Genkwa Flos/glycyrrhizic acid supramolecular complex were compared through in vitro studies on L-02 cells using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay; and 4',6-diamidino-2-phenylindole (DAPI) staining was performed to further confirm the enhancement inhibition of Genkwa Flos/glycyrrhizic acid supramolecular complex than Genkwa Flos. This study provides fundamental scientific evidence of the formation of a self-assembled phytochemical supramolecular when Genkwa Flos and glycyrrhizic acid are combined, enabling to understand their clinical incompatibility and contraindication.Entities:
Keywords: genkwa flos; glycyrrhizic acid; self-assembled supramolecular technology; toxicity; ultra-high-performance liquid chromatography coupled with quadrupole-orbitrap high-resolution mass spectrometry
Year: 2021 PMID: 35004606 PMCID: PMC8733466 DOI: 10.3389/fchem.2021.740952
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
FIGURE 1Microscopic morphology of the self-assembled complex. (A) Photographs of self-assemblies (1: Genkwa Flos; 2: the hydrogel of Genkwa Flos and glycyrrhizic acid). (B) Particle size of the Genkwa Flos/glycyrrhizic acid self-assembled complex. (C) Zeta potential of the Genkwa Flos/glycyrrhizic acid self-assembled complex. SEM images of (D) Genkwa Flos and (E) Genkwa Flos/glycyrrhizic acid self-assembled complex.
FIGURE 2TICC of the Genkwa Flos/glycyrrhizic acid self-assembled complex obtained in ESI+ mode.
Information on the constituents identified in Genkwa Flos/glycyrrhizic acid self-assembled complex in positive ionization mode.
| No | Compounds | Formula | Retention time (min) | Identity | Precursor ion | Fragment ions ( | ||
|---|---|---|---|---|---|---|---|---|
| Experimental ( | Theoretical ( | Mass accuracy (△ppm) | ||||||
| 1 | trigonelline | C7H7NO2 | 0.86 | [M+H]+ | 138.0549 | 138.0550 | –0.36 | 94.0653, 79.0417 |
| 2 | adenine | C5H5N5 | 0.93 | [M+H]+ | 136.0617 | 136.0618 | –0.73 | 119.0353 |
| 3 | phenylacetaldehyde | C8H8O | 1.36 | [M+H]+ | 121.0648 | 121.0648 | 0.00 | 103.0543, 93.0701 |
| 4 | L-leucine | C6H13NO2 | 1.45 | [M+H]+ | 132.1018 | 132.1019 | –0.76 | 86.0965, 69.0700 |
| 5 | L-phenylalanine | C9H11NO2 | 1.70 | [M+H]+ | 166.0862 | 166.0863 | –0.60 | 120.0808, 103.0543 |
| 6 | guanosine | C10H13N5O5 | 1.84 | [M+H]+ | 284.0987 | 284.0989 | –0.70 | 152.0568, 135.0302, 110.0350 |
| 7 | iso-guanosine | C10H13N5O5 | 1.84 | [M+H]+ | 284.0987 | 284.0989 | –0.70 | 152.0568, 110.0350 |
| 8 | adenosine | C10H13N5O4 | 1.86 | [M+H]+ | 268.1036 | 268.1040 | –1.49 | 268.1046, 136.0619 |
| 9 | chlorogenic acids | C16H18O9 | 2.26 | [M+H]+ | 355.1020 | 355.1024 | –1.13 | 163.0389, 145.0285, 135.0441, 117.0334, 79.0544 |
| 10 | neochlorogenic acid | C16H18O9 | 2.26 | [M+H]+ | 355.1020 | 355.1024 | –1.13 | 163.0389, 145.0285, 135.0441, 117.0334, 79.0544 |
| 11 | cryptochlorogenic acid | C16H18O9 | 2.26 | [M+H]+ | 355.1020 | 355.1024 | –1.13 | 163.0389, 145.0285, 135.0441, 117.0334, 79.0544 |
| 12 | scopolin | C16H18O9 | 2.26 | [M+H]+ | 355.1020 | 355.1024 | –1.13 | 163.0389, 135.0441, 145.0285, 117.0334, 89.0385 |
| 13 | 7-hydroxycoumarin | C9H6O3 | 2.28 | [M+H]+ | 163.0387 | 163.0390 | –1.84 | 145.0283, 135.0442, 53.0390 |
| 14 | schaftoside | C26H28O14 | 3.51 | [M+H]+ | 565.1544 | 565.1551 | –1.24 | 403.1004, 313.0697, 271.0598 |
| 15 | diosmetin | C16H12O6 | 3.80 | [M+H]+ | 301.0700 | 301.0707 | –2.33 | 286.0469, 258.0520, 241.0480, 135.0440, 124.0156 |
| No | Compounds | Formula | Retention time (min) | Identity | Precursor ion | Fragment ions ( | ||
| Experimental ( | Theoretical ( | Mass accuracy (△ppm) | ||||||
| 16 | genkwanin-5-O- | C27H30O14 | 4.00 | [M+H]+ | 579.1706 | 579.1708 | –0.35 | 431.1313, 285.0753, 271.0595 |
| 17 | luteoloside | C21H20O11 | 4.03 | [M+H]+ | 449.1074 | 449.1078 | –0.89 | 287.0548, 271.0598, 153.0181, 127.0390 |
| 18 | astragalin | C21H20O11 | 4.03 | [M+H]+ | 449.1074 | 449.1078 | –0.89 | 287.0548, 271.0598, 153.0181, 127.0390 |
| 19 | 3-O- | C21H20O11 | 4.03 | [M+H]+ | 449.1074 | 449.1078 | –0.89 | 287.0548, 271.0598, 153.0181, 127.0390 |
| 20 | vitexin | C21H20O10 | 4.04 | [M+H]+ | 433.1133 | 433.1129 | 0.92 | 415.1021, 397.0919, 367.0819, 337.0706, 313.0706, 283.0600, |
| 21 | apigenin-7-O- | C21H20O10 | 4.04 | [M+H]+ | 433.1133 | 433.1129 | 0.92 | 415.1021, 397.0919, 367.0819, 351.0870, 313.0706, 297.0759, 283.0600, 271.0593 |
| 22 | 5-hydroxy-6,4′-dimethoxyflavone-7-O- | C23H24O11 | 4.21 | [M+H]+ | 477.1388 | 477.1391 | –0.63 | 315.0862, 300.0627, 272.0674 |
| 23 | 5,4′-dihydroxy-7,3′-dimethoxyluteolin | C17H14O6 | 4.22 | [M+H]+ | 315.0858 | 315.0863 | –1.59 | 300.0626, 272.0679, 257.0433, 167.0340 |
| 24 | genkwanin-5-O- | C22H22O10 | 4.24 | [M+H]+ | 447.1280 | 447.1285 | –1.12 | 285.0757, 271.0596, 242.0571, 127.0387, 109.0280 |
| No | Compounds | Formula | Retention time (min) | Identity | Precursor ion | Fragment ions ( | ||
| Experimental ( | Theoretical ( | Mass accuracy (△ppm) | ||||||
| 25 | kaempferol-3-O-glucorhamnoside | C27H30O15 | 4.32 | [M+H]+ | 595.1658 | 595.1657 | 0.17 | 301.0706, 271.0590, 4,109.0282 |
| 26 | 5, 6-dihydroxy flavanone - 7-o-glucoside acid | C21H20O11 | 4.42 | [M+H]+ | 449.1088 | 449.1078 | 2.23 | 273.0758, 171.0285, 153.0183, 121.0646 |
| 27 | isodaphnoretin | C19H12O7 | 4.51 | [M+H]+ | 353.0654 | 353.0655 | –0.28 | 192.0417, 177.0181, 163.0387, 161.0240, 146.0362, 135.0441, |
| 28 |
| C15H22O | 4.57 | [M+H]+ | 219.1743 | 219.1743 | –0.18 | 175.1481, 161.1324, 133.1013, 119.0854, 107.0854, 105.0700 |
| 29 | genistin | C21H20O10 | 4.59 | [M+H]+ | 433.1133 | 433.1129 | 0.92 | 271.0601, 153.0181, 127.0389 |
| 30 | cosnosiin | C21H20O10 | 4.59 | [M+H]+ | 433.1133 | 433.1129 | 0.92 | 271.0601, 153.0181, 127.0389 |
| 31 | apigenin | C15H10O5 | 4.62 | [M+H]+ | 271.0600 | 271.0601 | 0.48 | 243.0653, 153.0183, 119.0492 |
| 32 | genkwanin | C16H12O5 | 4.77 | [M+H]+ | 285.0757 | 285.0758 | 0.35 | 270.0521, 257.0812, 242.0572, 197.0594, 167.0339, 124.0156 |
| 33 | oroxylin | C16H12O5 | 4.77 | [M+H]+ | 285.0757 | 285.0758 | 0.35 | 270.0521, 257.0812, 242.0572, 197.0594, 167.0339, 124.0156, |
| 34 | wogonin | C16H12O5 | 4.77 | [M+H]+ | 285.0757 | 285.0758 | 0.35 | 270.0521, 257.0812, 242.0572, 197.0594, 167.0339, 124.0156 |
| No | Compounds | Formula | Retention time (min) | Identity | Precursor ion | Fragment ions ( | ||
| Experimental ( | Theoretical ( | Mass accuracy (△ppm) | ||||||
| 35 | calycosin | C16H12O5 | 4.77 | [M+H]+ | 285.0757 | 285.0758 | 0.35 | 270.0521, 257.0812, 242.0572, 225.0549 |
| 36 | tiliroside | C30H26O13 | 4.78 | [M+H]+ | 595.1437 | 595.1446 | –1.51 | 309.0966, 287.0547, 165.0545, 147.0439, 119.0491, |
| 37 | kaempferol | C15H10O6 | 4.80 | [M+H]+ | 287.0546 | 287.0550 | –1.39 | 269.0438, 259.0596, 243.0636, 231.0650, 213.0544, 153.0182 |
| 38 | luteolin | C15H10O6 | 4.80 | [M+H]+ | 287.0546 | 287.0550 | –1.39 | 269.0438, 259.0596, 241.0494, 213.0544, 153.0182, 135.0440, |
| 39 | scutellarein | C15H10O6 | 4.80 | [M+H]+ | 287.0546 | 287.0550 | –1.39 | 269.0438, 259.0596, 241.0494, 171.0285, 153.0182, 125.0236 |
| 40 | 7-methoxy-luteolin-5-O- | C22H22O11 | 5.38 | [M+H]+ | 463.1229 | 463.1234 | –1.08 | 301.0705, 287.0544, 258.0527, 167.0335, |
| 41 | wogonoside | C22H20O11 | 5.48 | [M+H]+ | 461.1084 | 461.1078 | 1.30 | 271.0601 |
| 42 | melaleuca papyrin a-7-O- | C22H20O11 | 5.48 | [M+H]+ | 461.1084 | 461.1078 | 1.30 | 271.0601 |
| 43 | sakuranetin | C16H14O5 | 5.51 | [M+H]+ | 287.0914 | 287.0914 | 0.00 | 137.0235 |
| 44 | hydroxygenkwanin | C16H12O6 | 5.92 | [M+H]+ | 301.0707 | 301.0707 | 0.07 | 286.0471, 258.0521, 241.0489, 167.0339, 135.0439, 124.0155 |
| 45 | hispidulin | C16H12O6 | 5.92 | [M+H]+ | 301.0700 | 301.0707 | –2.33 | 286.0471, 258.0521, 241.0489 |
|
| Compounds | Formula | Retention time (min) | Identity | Precursor ion | Fragment ions ( | ||
| Experimental ( | Theoretical ( | Mass accuracy (△ppm) | ||||||
| 46 | 3, 7-dimethoxy-5, 4′-dihydroxyflavone | C17H14O6 | 6.38 | [M+H]+ | 315.0858 | 315.0863 | –1.59 | 300.0626, 285.0375, 272.0676, 257.0435, 167.0336 |
| 47 | 3′, 4′-dihydroxy-3, 7-dimethoxyflavone | C17H14O6 | 6.38 | [M+H]+ | 315.0858 | 315.0863 | –1.59 | 300.0628, 272.0676, 285.0375, 257.0435 |
| 48 | 3′, 4′-dihydroxy-3, 8-dimethoxyflavone | C17H14O6 | 6.38 | [M+H]+ | 315.0858 | 315.0863 | –1.59 | 300.0628, 272.0676, 285.0375, 257.0435 |
| 49 | 5, 7-dihydroxy-6, 8-dimethoxyflavone | C17H14O6 | 6.38 | [M+H]+ | 315.0858 | 315.0863 | –1.59 | 300.0628, 272.0676, 285.0375, 257.0435 |
| 50 | yuanhuafine | C29H32O10 | 7.82 | [M+H]+ | 541.2070 | 541.2068 | 0.37 | 487.1727, 359.1476, 341.1390, 323.1280, 313.1433, 295.1329 |
| 51 | yuanhuatine | C34H34O10 | 7.98 | [M+H]+ | 603.2220 | 603.2224 | –0.66 | 359.1485, 341.1387, 323.1276, 319.1168, 313.1436, 295.1331 |
| 52 | genkwadaphnine | C34H34O10 | 7.98 | [M+H]+ | 603.2220 | 603.2224 | –0.66 | 359.1485, 341.1387, 323.1276, 319.1168, 313.1436, 295.1331 |
| 53 | daphne diterpene ester-7 | C37H46O11 | 9.51 | [M+H]+ | 667.3117 | 667.3112 | 0.75 | 631.2869, 545.2733, 509.2534, 377.1599, 359.1483, 341.1381, |
| 54 | yuanhuadine | C32H42O10 | 9.64 | [M+H]+ | 587.2848 | 587.2850 | –0.34 | 569.2775, 551.2692, 509.2544, 491.2425, 359.1486, 341.1381, |
| No | Compounds | Formula | Retention time (min) | Identity | Precursor ion | Fragment ions ( | ||
| Experimental ( | Theoretical ( | Mass accuracy (△ppm) | ||||||
| 55 | yuanhuacine | C37H44O10 | 10.64 | [M+H]+ | 649.3001 | 649.3007 | 0.92 | 359.1476, 341.1381, 323.1273, 313.1431, 295.1325 |
| 56 | genkwanine H | C34H40O10 | 11.41 | [M+H]+ | 609.2666 | 609.2694 | –4.60 | 591.2605 |
| 57 | Yuanhuapine | C29H34O10 | 11.86 | [M+H]+ | 543.2227 | 543.2225 | 0.37 | 507.2020, 471.1787, 447.1801, 361.1631 |
| 58 | 7-ketositosterol | C29H48O2 | 14.80 | [M+H]+ | 429.3725 | 429.3727 | –0.47 | 411.3622, 369.3159, 271.2055, 231.1741, 217.1573, 203.1431, |
FIGURE 3Product ion spectra of (A) yuanhuacine and (B) yuanhuadine.
FIGURE 4Product ion spectra of (A) genkwanin and (B) genkwanin-5-O-β-D-glucoside.
FIGURE 5Product ion spectra of (A) isodaphnoretin and (B) 7-ketositosterol.
FIGURE 61H-NMR spectrum of (A) the yuanhuacine/glycyrrhizic acid self-assembled complex (B) glycyrrhizic acid, and (C) yuanhuacine.
FIGURE 7The self-assembly mechanism of the yuanhuacine/glycyrrhizic acid self-assembled complex (A) NOESY 2D 1H-NMR spectra of the yuanhuacine/glycyrrhizic acid self-assembled complex. (B) Chemdraw and (C) Chemdraw 3D of the yuanhuacine/glycyrrhizic acid self-assembled complex.
FIGURE 8Chromatograms of (A) Genkwa Flos and (B) the Genkwa Flos/glycyrrhizic acid self-assembled complex (C) The in vitro cytotoxicity of Genkwa Flos and the Genkwa Flos/glycyrrhizic acid self-assembled complex against L-02 cells. *p < 0.05. (D–I) Morphological detection of apoptosis using DAPI staining (100 ×) on L-02 cells treated with Genkwa Flos and the Genkwa Flos/glycyrrhizic acid self-assembled complex: (G) control group, (H) 0.15625 mg/ml Genkwa Flos, and (I) 0.15625 mg/ml Genkwa Flos/glycyrrhizic acid self-assembled complex.